Table 1 Demographics and clinical data of patients with ankylosing spondylitis and healthy control subjects
Patients with AS (n = 24) | Healthy control subjects (n = 16) | P value | |
|---|---|---|---|
Age (years) | 39.5 (33.0–57.8) | 39.0 (33.5–43.5) | 0.313 |
Sex (M:F) | 12:4 | 12:4 | > 0.999 |
HLA-B27+ | 24 (100%) | – | |
C-reactive protein (mg/dl) | 0.24 (0.08–1.24) | – | |
Medication | |||
NSAID | 23 (95.8%) | – | |
Salazopyrine | 24 (100%) | – | |
Anti-TNF therapy | 14 (58.3%) | – | |